• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性丙型肝炎病毒感染患者肝组织和白细胞中IRS1的表达:一项对比研究。

IRS1 Expression in Hepatic Tissue and Leukocytes in Chronic Hepatitis C Virus Infected Patients: A Comparative Study.

作者信息

Kappel Camila Ripoll, Kretzmann Nélson A, Alvares-da-Silva Mário Reis

机构信息

Gastroenterology and Hepatology Post-Graduate Course, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

出版信息

Int J Hepatol. 2012;2012:698905. doi: 10.1155/2012/698905. Epub 2012 Jul 5.

DOI:10.1155/2012/698905
PMID:22830036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3398587/
Abstract

Aims. To determine lymphocyte IRS (IRS1 cells) in HCV patients, correlating it to liver IRS (IRS 1liver) and HOMA-IR. This study tested the hypothesis that IRS1 cells expression can be used as insulin resistance (IR) marker in HCV-infected patients. IRS1 cells were not studied before in HCV infection. Materials and Methods. HCV chronically infected patients, naïve, nonobese, noncirrhotic, and nondiabetic were prospectively included and compared to controls (blood donors). Blood was taken, and leukocytes were separated. IRS1 was determined by real-time PCR. Liver tissue was obtained from transplant donors as controls. Results. 41 HCV-positive patients were included, 26 males (60.5%); mean age of 45 (±7.9); 33 (80.5%) from genotype 1. 6 out of 12 controls were males (50%); mean age was 26.7 (±3.2). There was expression of IRS1 in leukocytes. The median IRS1 cells (HCV) were 0.061 (0.004 to 0.469); the median IRS 1liver (HCV) was 0.0003 (0.00002 to 0.0186)-lower than in controls (resp., P = 0.005 and P = 0.018). HOMA-IR had an inverse correlation with IRS 1liver (P = 0.04). There was no correlation between IRS1 liver and IRS1 cells (P = 0.930). Conclusions. There was expression of IRS1 in leukocytes. IRS1 cells and IRS1 liver were lower in HCV patients than in controls.

摘要

目的。确定丙型肝炎病毒(HCV)患者的淋巴细胞胰岛素受体底物(IRS,IRS1细胞),并将其与肝脏胰岛素受体底物(IRS 1肝脏)和稳态模型评估胰岛素抵抗(HOMA-IR)相关联。本研究检验了以下假设:IRS1细胞表达可作为HCV感染患者胰岛素抵抗(IR)的标志物。此前尚未对HCV感染中的IRS1细胞进行研究。材料与方法。前瞻性纳入慢性HCV感染患者,这些患者未接受过治疗、非肥胖、非肝硬化且非糖尿病,并与对照组(献血者)进行比较。采集血液并分离白细胞。通过实时聚合酶链反应(PCR)测定IRS1。从移植供体获取肝脏组织作为对照。结果。纳入41例HCV阳性患者,其中26例男性(60.5%);平均年龄45岁(±7.9岁);33例(80.5%)为基因1型。12例对照组中有6例男性(50%);平均年龄为26.7岁(±3.2岁)。白细胞中存在IRS1表达。IRS1细胞(HCV)的中位数为0.061(0.004至0.469);IRS 1肝脏(HCV)的中位数为0.0003(0.00002至0.0186),低于对照组(分别为P = 0.005和P = 0.018)。HOMA-IR与IRS 1肝脏呈负相关(P = 0.04)。IRS1肝脏与IRS1细胞之间无相关性(P = 0.930)。结论。白细胞中存在IRS1表达。HCV患者的IRS1细胞和IRS1肝脏低于对照组。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a7e/3398587/34670622aa89/IJHEP2012-698905.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a7e/3398587/34670622aa89/IJHEP2012-698905.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a7e/3398587/34670622aa89/IJHEP2012-698905.001.jpg

相似文献

1
IRS1 Expression in Hepatic Tissue and Leukocytes in Chronic Hepatitis C Virus Infected Patients: A Comparative Study.慢性丙型肝炎病毒感染患者肝组织和白细胞中IRS1的表达:一项对比研究。
Int J Hepatol. 2012;2012:698905. doi: 10.1155/2012/698905. Epub 2012 Jul 5.
2
Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.丙型肝炎病毒的清除可改善胰岛素抵抗、β细胞功能以及胰岛素受体底物1和2的肝脏表达。
Am J Gastroenterol. 2007 Mar;102(3):570-6. doi: 10.1111/j.1572-0241.2006.01038.x.
3
Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients.在非肥胖和非糖尿病患者中,丙型肝炎病毒直接与胰岛素抵抗相关,且与内脏脂肪面积无关。
J Viral Hepat. 2007 Sep;14(9):600-7. doi: 10.1111/j.1365-2893.2006.00836.x.
4
Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.血清胰岛素样生长因子-1(IGF-1)水平与丙型肝炎病毒感染和胰岛素抵抗的关系。
Transl Res. 2011 Sep;158(3):155-62. doi: 10.1016/j.trsl.2011.04.005. Epub 2011 May 30.
5
Insulin resistance in nondiabetic Egyptian patients with chronic hepatitis C virus.非糖尿病埃及慢性丙型肝炎病毒患者的胰岛素抵抗。
Rev Gastroenterol Mex (Engl Ed). 2020 Apr-Jun;85(2):173-179. doi: 10.1016/j.rgmx.2019.05.005. Epub 2019 Nov 26.
6
Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes.丙型肝炎病毒患者中胰岛素受体底物-1/磷脂酰肌醇-3激酶信号通路受损:2型糖尿病患病率增加的一种机制
Hepatology. 2003 Dec;38(6):1384-92. doi: 10.1016/j.hep.2003.09.012.
7
Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.丙型肝炎病毒通过上调细胞因子信号转导抑制因子3来下调胰岛素受体底物1和2。
Am J Pathol. 2004 Nov;165(5):1499-508. doi: 10.1016/S0002-9440(10)63408-6.
8
HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients.稳态模型评估的胰岛素抵抗指数(HOMA-AD)在评估非肝硬化瘦型丙型肝炎门诊患者胰岛素抵抗中的应用
Int J Hepatol. 2012;2012:576584. doi: 10.1155/2012/576584. Epub 2012 Jul 16.
9
SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells.1型和2型丙型肝炎病毒感染的HepG2细胞中,SOCS3和IRS-1基因表达存在差异。
Clin Chem Lab Med. 2009;47(10):1217-25. doi: 10.1515/CCLM.2009.280.
10
Altering retinol binding protein 4 levels in hepatitis C: Inflammation and steatosis matter.改变丙型肝炎中视黄醇结合蛋白 4 水平:炎症和脂肪变性很重要。
Virulence. 2020 Dec;11(1):1501-1511. doi: 10.1080/21505594.2020.1838742.

引用本文的文献

1
Diabetes and infections-hepatitis C: is there type 2 diabetes excess in hepatitis C infection?糖尿病与感染-丙型肝炎:丙型肝炎感染中是否存在 2 型糖尿病过度发生?
Curr Diab Rep. 2013 Jun;13(3):428-34. doi: 10.1007/s11892-013-0370-3.

本文引用的文献

1
Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis.慢性 HCV 感染是动脉粥样硬化的一个危险因素。HCV 及 HCV 相关脂肪变性的作用。
Atherosclerosis. 2012 Apr;221(2):496-502. doi: 10.1016/j.atherosclerosis.2012.01.051. Epub 2012 Feb 8.
2
The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy.接受聚乙二醇干扰素联合利巴韦林治疗的糖尿病前期慢性丙型肝炎患者葡萄糖异常的结局。
Liver Int. 2012 Jul;32(6):962-9. doi: 10.1111/j.1478-3231.2012.02771.x. Epub 2012 Feb 22.
3
Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations.
颈动脉粥样硬化与慢性丙型肝炎:风险关联的前瞻性研究。
Hepatology. 2012 May;55(5):1317-23. doi: 10.1002/hep.25508. Epub 2012 Apr 4.
4
Decreased IRS2 and TIMP3 expression in monocytes from offspring of type 2 diabetic patients is correlated with insulin resistance and increased intima-media thickness.2 型糖尿病患者子代单核细胞中 IRS2 和 TIMP3 表达降低与胰岛素抵抗和内膜中层厚度增加相关。
Diabetes. 2011 Dec;60(12):3265-70. doi: 10.2337/db11-0162. Epub 2011 Oct 7.
5
Effects of hepatitis C virus on cardiovascular risk in infected patients: a comparative study.丙型肝炎病毒对感染患者心血管风险的影响:一项对比研究。
Int J Cardiol. 2013 Apr 5;164(2):221-6. doi: 10.1016/j.ijcard.2011.07.016. Epub 2011 Jul 23.
6
Meta-analysis: insulin resistance and sustained virological response in hepatitis C.Meta 分析:胰岛素抵抗与丙型肝炎持续病毒学应答
Aliment Pharmacol Ther. 2011 Aug;34(3):297-305. doi: 10.1111/j.1365-2036.2011.04716.x. Epub 2011 May 29.
7
Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.肝胰岛素抵抗与非酒精性脂肪性肝炎和慢性丙型肝炎中的细胞凋亡和纤维化增加有关。
J Hepatol. 2011 Jan;54(1):142-52. doi: 10.1016/j.jhep.2010.06.021. Epub 2010 Aug 27.
8
Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.慢性丙型肝炎与外周而非肝脏胰岛素抵抗有关。
Gastroenterology. 2010 Mar;138(3):932-41.e1-3. doi: 10.1053/j.gastro.2009.11.050. Epub 2009 Dec 4.
9
Steatosis and insulin resistance in hepatitis C: a way out for the virus?丙型肝炎中的脂肪变性和胰岛素抵抗:病毒的出路?
World J Gastroenterol. 2009 Oct 28;15(40):5014-9. doi: 10.3748/wjg.15.5014.
10
Successful intensive insulin treatment of type 1 diabetic dogs leads to restoration of peripheral leukocyte insulin signaling gene expression and enzyme activities.对1型糖尿病犬进行成功的强化胰岛素治疗可导致外周白细胞胰岛素信号基因表达和酶活性的恢复。
J Vet Med Sci. 2009 Aug;71(8):1017-26. doi: 10.1292/jvms.71.1017.